Annual D&A
$194.30 K
+$14.60 K+8.12%
30 September 2023
Summary:
Citius Pharmaceuticals annual depreciation & amortization is currently $194.30 thousand, with the most recent change of +$14.60 thousand (+8.12%) on 30 September 2023. During the last 3 years, it has risen by +$29.40 thousand (+17.83%). CTXR annual D&A is now at all-time high.CTXR Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$52.80 K
+$700.00+1.34%
30 June 2024
Summary:
Citius Pharmaceuticals quarterly depreciation & amortization is currently $52.80 thousand, with the most recent change of +$700.00 (+1.34%) on 30 June 2024. Over the past year, it has increased by +$2800.00 (+5.60%). CTXR quarterly D&A is now at all-time high.CTXR Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$205.90 K
+$3800.00+1.88%
30 June 2024
Summary:
Citius Pharmaceuticals TTM depreciation & amortization is currently $205.90 thousand, with the most recent change of +$3800.00 (+1.88%) on 30 June 2024. Over the past year, it has increased by +$11.60 thousand (+5.97%). CTXR TTM D&A is now at all-time high.CTXR TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CTXR Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +5.6% | +6.0% |
| 3 y3 years | +17.8% | +23.4% | +24.9% |
| 5 y5 years | +10000.0% | +10000.0% | +10000.0% |
CTXR Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +17.8% | at high | +23.4% | at high | +24.9% |
| 5 y | 5 years | at high | >+9999.0% | at high | >+9999.0% | at high | >+9999.0% |
| alltime | all time | at high | at high | at high |
Citius Pharmaceuticals Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2024 | - | $52.80 K(+1.3%) | $205.90 K(+1.9%) |
| Mar 2024 | - | $52.10 K(+2.2%) | $202.10 K(+2.0%) |
| Dec 2023 | - | $51.00 K(+2.0%) | $198.10 K(+2.0%) |
| Sept 2023 | $194.30 K(+8.1%) | $50.00 K(+2.0%) | $194.30 K(+2.0%) |
| June 2023 | - | $49.00 K(+1.9%) | $190.50 K(+2.0%) |
| Mar 2023 | - | $48.10 K(+1.9%) | $186.80 K(+2.0%) |
| Dec 2022 | - | $47.20 K(+2.2%) | $183.20 K(+2.0%) |
| Sept 2022 | - | $46.20 K(+2.0%) | $179.60 K(+1.9%) |
| Sept 2022 | $179.70 K(+9.0%) | - | - |
| June 2022 | - | $45.30 K(+1.8%) | $176.20 K(+2.1%) |
| Mar 2022 | - | $44.50 K(+2.1%) | $172.60 K(+2.3%) |
| Dec 2021 | - | $43.60 K(+1.9%) | $168.70 K(+2.3%) |
| Sept 2021 | $164.90 K(+8.2%) | $42.80 K(+2.6%) | $164.90 K(+2.3%) |
| June 2021 | - | $41.70 K(+2.7%) | $161.20 K(+7.1%) |
| Mar 2021 | - | $40.60 K(+2.0%) | $150.50 K(-4.4%) |
| Dec 2020 | - | $39.80 K(+1.8%) | $157.40 K(+3.3%) |
| Sept 2020 | $152.40 K | $39.10 K(+26.1%) | $152.30 K(+34.3%) |
| June 2020 | - | $31.00 K(-34.7%) | $113.40 K(+37.3%) |
| Mar 2020 | - | $47.50 K(+36.9%) | $82.60 K(+134.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | - | $34.70 K(>+9900.0%) | $35.30 K(+4312.5%) |
| Sept 2019 | $900.00(-50.0%) | $200.00(0.0%) | $800.00(0.0%) |
| June 2019 | - | $200.00(0.0%) | $800.00(0.0%) |
| Mar 2019 | - | $200.00(0.0%) | $800.00(-33.3%) |
| Dec 2018 | - | $200.00(0.0%) | $1200.00(-25.0%) |
| Sept 2018 | $1800.00(-30.8%) | $200.00(0.0%) | $1600.00(-20.0%) |
| June 2018 | - | $200.00(-66.7%) | $2000.00(-20.0%) |
| Mar 2018 | - | $600.00(0.0%) | $2500.00(-3.8%) |
| Dec 2017 | - | $600.00(0.0%) | $2600.00(-3.7%) |
| Sept 2017 | $2600.00(+100.0%) | $600.00(-14.3%) | $2700.00(-3.6%) |
| June 2017 | - | $700.00(0.0%) | $2800.00(0.0%) |
| Mar 2017 | - | $700.00(0.0%) | $2800.00(+33.3%) |
| Dec 2016 | - | $700.00(0.0%) | $2100.00(+50.0%) |
| Sept 2016 | $1300.00(>+9900.0%) | $700.00(0.0%) | $1400.00(+100.0%) |
| June 2016 | - | $700.00(>+9900.0%) | $700.00(>+9900.0%) |
| Mar 2016 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2015 | - | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2015 | $0.00 | $0.00(0.0%) | $0.00(0.0%) |
| June 2015 | - | $0.00 | $0.00 |
FAQ
- What is Citius Pharmaceuticals annual depreciation & amortization?
- What is the all time high annual D&A for Citius Pharmaceuticals?
- What is Citius Pharmaceuticals quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Citius Pharmaceuticals?
- What is Citius Pharmaceuticals quarterly D&A year-on-year change?
- What is Citius Pharmaceuticals TTM depreciation & amortization?
- What is the all time high TTM D&A for Citius Pharmaceuticals?
- What is Citius Pharmaceuticals TTM D&A year-on-year change?
What is Citius Pharmaceuticals annual depreciation & amortization?
The current annual D&A of CTXR is $194.30 K
What is the all time high annual D&A for Citius Pharmaceuticals?
Citius Pharmaceuticals all-time high annual depreciation & amortization is $194.30 K
What is Citius Pharmaceuticals quarterly depreciation & amortization?
The current quarterly D&A of CTXR is $52.80 K
What is the all time high quarterly D&A for Citius Pharmaceuticals?
Citius Pharmaceuticals all-time high quarterly depreciation & amortization is $52.80 K
What is Citius Pharmaceuticals quarterly D&A year-on-year change?
Over the past year, CTXR quarterly depreciation & amortization has changed by +$2800.00 (+5.60%)
What is Citius Pharmaceuticals TTM depreciation & amortization?
The current TTM D&A of CTXR is $205.90 K
What is the all time high TTM D&A for Citius Pharmaceuticals?
Citius Pharmaceuticals all-time high TTM depreciation & amortization is $205.90 K
What is Citius Pharmaceuticals TTM D&A year-on-year change?
Over the past year, CTXR TTM depreciation & amortization has changed by +$11.60 K (+5.97%)